Literature DB >> 22484210

Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.

Silvia Pescina1, Patrizia Santi, Giulio Ferrari, Cristina Padula, Pierugo Cavallini, Paolo Govoni, Sara Nicoli.   

Abstract

Trans-scleral delivery is nowadays considered as a possible way to deliver drugs to the posterior segment of the eye. Despite the potentiality of this administration route, there is a lack of fundamental knowledge on the role of the numerous barriers involved. The aim of this work was to develop an easy and cheap ex vivo method to evaluate the barrier properties of the choroid-Bruch's layer and in particular to estimate the role of melanin in drug diffusion through ocular tissues. In vitro binding studies were performed to estimate drug affinity for melanin; model molecules used were methylene blue, propranolol, levofloxacin and methylprednisolone sodium succinate. The ex vivo model set up is based on porcine eye bulbs with light blue iris or brown iris. While the choroid of brown eyes is dark, the choroid of blue eyes is transparent, due to the absence of melanin. Permeation experiments using pigmented and not-pigmented porcine tissues gave the opportunity to discriminate between the barrier role of choroid-Bruch's membrane as such and the barrier role of melanin. Ex vivo permeation experiments can be performed using isolated choroid-Bruch's or the sclera-choroid-Bruch's layer. In this last case, it is possible to take into account also the barrier role of the sclera that tends to decrease the drug concentration at the sclera/choroid interface, thus amplifying the effect of melanin. The data obtained in this paper indicate that for some drugs melanin can really represent a barrier and the effect can imply a lower drug flux or simply a longer lag time depending on the kind of drug and the concentration applied. However, it is a saturable barrier, thus its effect can probably be overtaken by high doses or multiple administrations. The ex vivo model set up can help to refine computational models, to better evaluate the interplay among static, dynamic and metabolic barriers. Additionally, since human eyes display a full range of pigmentation, the model could also be useful to investigate the possible influence of pigmentation phenotype on trans-scleral delivery.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484210     DOI: 10.1016/j.ejps.2012.03.013

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Prediction of passive drug permeability across the blood-retinal barrier.

Authors:  Aapo Tervonen; Iina Vainio; Soile Nymark; Jari Hyttinen
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

2.  Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier.

Authors:  Rajendra S Kadam; Robert I Scheinman; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-10-15       Impact factor: 4.939

3.  Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit.

Authors:  Xuetao Huang; Manqiang Peng; Yezhen Yang; Yiqin Duan; Kuanshu Li; Shaogang Liu; Changhua Ye; Ding Lin
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 4.  Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Authors:  Hanaa A Galeb; Emma L Wilkinson; Alison F Stowell; Hungyen Lin; Samuel T Murphy; Pierre L Martin-Hirsch; Richard L Mort; Adam M Taylor; John G Hardy
Journal:  Glob Chall       Date:  2020-11-25

Review 5.  Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers.

Authors:  Yingke Liu; Zhihe Zhao; Man Li
Journal:  Asian J Pharm Sci       Date:  2022-06-23       Impact factor: 9.273

6.  Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye.

Authors:  Silvia Pescina; Fabio Sonvico; Adryana Clementino; Cristina Padula; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.